You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-cell maturation antigen (BCMA)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Cavity Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in Guangzhou

Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +2 more
  • Sintilimab, Nab-paclitaxel, Carboplatin
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Oct 20, 2021

Acute Respiratory Distress Syndrome Trial in Shanghai (low dose hMSC-Exos, medium dose hMSC-Exos, high dose hMSC-Exos)

Unknown status
  • Acute Respiratory Distress Syndrome
  • low dose hMSC-Exos
  • +5 more
  • Shanghai, Shanghai, China
    Ruijin Hospital, Medical School of Shanghai Jiaotong University
Nov 1, 2021

Penile Cancer, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)

Recruiting
  • Penile Cancer
  • Margin Assessment
  • Groningen, Netherlands
    University Medical Center Groningen
May 16, 2022

Pleural Mesothelioma Malignant Advanced Trial in Worldwide (Carboplatin, Pemetrexed, Bevacizumab)

Active, not recruiting
  • Pleural Mesothelioma Malignant Advanced
  • Leuven, Belgium
  • +41 more
Aug 23, 2022

NSCLC Trial in San Antonio (bexmarilimab (FP-1305), Pembrolizumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • San Antonio, Texas
    Mays Cancer Center, UT Health San Antonio
May 13, 2022

KRAS Gene Mutation Trial in Cincinnati, Dallas (TVB-2640)

Recruiting
  • KRAS Gene Mutation
  • Cincinnati, Ohio
  • +1 more
Dec 19, 2022

Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)

Recruiting
  • Hodgkin's Lymphoma
  • Bydgoszcz, Poland
  • +12 more
Dec 23, 2021

Lung Tumor Malignant Trial in Milano (SBRT, Surgery)

Not yet recruiting
  • Lung Neoplasm Malignant
  • SBRT
  • Surgery
  • Milano, MI, Italy
    Istituto Europeo di Oncologia IRCCS
Jul 26, 2023

Lymphoma Trial in Worldwide (Ibrutinib, Placebo, Rituximab)

Completed
Has Results
  • Lymphoma
  • Tucson, Arizona
  • +205 more
Mar 30, 2020

Kidney Transplantation in Highly Sensitized Patients Trial in Prague, Barcelona, Madrid (Imlifidase, Normal Transplantation

Recruiting
  • Kidney Transplantation in Highly Sensitized Patients
  • Vienna, Austria
  • +9 more
Jan 24, 2023

Triple Negative Breast Cancer, Nonsmall Cell Lung Cancer Trial in Rocky Mount

Recruiting
  • Triple Negative Breast Cancer
  • Nonsmall Cell Lung Cancer
    • Rocky Mount, North Carolina
      Accellacare of Rocky Mount -Dr. Bondy
    May 26, 2023

    Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • (no location specified)
    May 22, 2023

    Severe Prednisone Dependent Eosinophilic Asthma Trial in Hamilton (Benralizumab, Placebo)

    Recruiting
    • Severe Prednisone Dependent Eosinophilic Asthma
    • Benralizumab
    • Placebo
    • Hamilton, Ontario, Canada
      Firestone Institute for Respiratory Health, Research - St. Josep
    Sep 6, 2021

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Westwood (EAGD T-cell infusion (Phase

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • EAGD T-cell infusion (Phase I)
    • EAGD T-cell infusion (Expansion)
    • Westwood, Kansas
      University of Kansas Cancer Center
    Mar 15, 2022

    Postgastrectomy Syndrome Trial in Islamabad (active release group, active control group)

    Not yet recruiting
    • Postgastrectomy Syndrome
    • active release group
    • active control group
    • Islamabad, Capital, Pakistan
      Federal Breast Cancer Screening center (PIMS)
    Aug 10, 2022

    Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy Trial in London (Autologous EBV-CTL

    Active, not recruiting
    • Post-transplant Lymphoproliferative Disease
    • Transplant-Related Hematologic Malignancy
    • Autologous EBV-CTL transduced with vector SFG-CNA12
    • +2 more
    • London, United Kingdom
    • +1 more
    Jan 19, 2022

    Cancer, BRAF V600 Mutation, Melanoma Trial (XP-102, Trametinib)

    Not yet recruiting
    • Cancer
    • +5 more
    • (no location specified)
    Aug 18, 2022

    EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type

    Recruiting
    • Type1 Diabetes Mellitus
    • Beta Cell Loss and Immune Function
    • Immune Function with RNAseq
    • Hope, California
    • +3 more
    Jun 1, 2022

    Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab)

    Recruiting
    • Head and Neck Cancer
    • Head and Neck Squamous Cell Carcinoma
    • Irvine, California
    • +10 more
    Nov 4, 2021

    COPD (COPD) Trial (Benralizumab, Benralizumab , Comparison (control) group; no intervention)

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease (COPD)
    • (no location specified)
    Apr 26, 2022

    Peri-implant Mucositis Trial in Cairo (Er: YAG laser, plasma spray)

    Completed
    • Peri-implant Mucositis
    • Er: YAG laser
    • plasma spray
    • Cairo, Egypt
      Ain Shams University -Faculty of dentistry
    Apr 4, 2023

    Abnormal Respiratory Cell Populations in Lung Cancer Screening

    Not yet recruiting
    • Lung Cancer
      • (no location specified)
      May 12, 2023

      Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

      Recruiting
      • Prostate Cancer
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins Hospital
      May 6, 2022

      Influenza Trial in Worldwide (Baloxavir Marboxil, Placebo)

      Recruiting
      • Influenza
      • Baloxavir Marboxil
      • Placebo
      • Birmingham, Alabama
      • +290 more
      Jan 20, 2023

      Cervical Cancer, Prostate Cancer Trial in San Francisco (Hyperthermia, HDR brachytherapy)

      Terminated
      • Cervical Cancer
      • Prostate Cancer
      • Hyperthermia
      • HDR brachytherapy
      • San Francisco, California
        University of California, San Francisco
      Jun 30, 2021